K Späthe

956 total citations
9 papers, 800 citations indexed

About

K Späthe is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, K Späthe has authored 9 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Reproductive Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in K Späthe's work include Ovarian cancer diagnosis and treatment (4 papers), Peptidase Inhibition and Analysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). K Späthe is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Peptidase Inhibition and Analysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). K Späthe collaborates with scholars based in Germany and United States. K Späthe's co-authors include Barbara Schmalfeldt, Walther Kuhn, Ursula Berger, Manfred Schmitt, Ernst Lengyel, Rafael Fridman, Dieter Prechtel, H. Graeff, Kurt Ulm and G. Florack and has published in prestigious journals such as Cancer, British Journal of Cancer and Gynecologic Oncology.

In The Last Decade

K Späthe

9 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K Späthe Germany	8	298	275	266	242	195	9	800
Nobuhiko Moniwa Japan	9	305 1.0×	223 0.8×	164 0.6×	201 0.8×	28 0.1×	15	685
Arnaud Da Cruz Paula United States	21	360 1.2×	332 1.2×	348 1.3×	290 1.2×	221 1.1×	74	1.2k
Jessica C.A. Bouma-ter Steege Netherlands	8	142 0.5×	198 0.7×	322 1.2×	410 1.7×	24 0.1×	9	851
Volker Moebus Germany	15	224 0.8×	144 0.5×	393 1.5×	164 0.7×	93 0.5×	52	705
Ayumi Hongo Japan	17	177 0.6×	56 0.2×	370 1.4×	508 2.1×	87 0.4×	31	944
Anil Sadarangani United States	15	270 0.9×	55 0.2×	183 0.7×	648 2.7×	80 0.4×	32	970
Elizabeth Masse United States	7	167 0.6×	129 0.5×	159 0.6×	370 1.5×	79 0.4×	8	625
Angela Thornton United States	9	102 0.3×	153 0.6×	275 1.0×	322 1.3×	56 0.3×	10	707
A Harłozińska Poland	14	76 0.3×	144 0.5×	219 0.8×	234 1.0×	83 0.4×	55	587
Karen A. Cadoo United States	19	162 0.5×	247 0.9×	365 1.4×	241 1.0×	75 0.4×	74	868

Countries citing papers authored by K Späthe

Since Specialization

Citations

This map shows the geographic impact of K Späthe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Späthe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Späthe more than expected).

Fields of papers citing papers by K Späthe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Späthe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Späthe. The network helps show where K Späthe may publish in the future.

Co-authorship network of co-authors of K Späthe

This figure shows the co-authorship network connecting the top 25 collaborators of K Späthe. A scholar is included among the top collaborators of K Späthe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Späthe. K Späthe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hilpert, Felix, Alexander Burges, K Späthe, et al.. (2005). Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy—a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group. Supportive Care in Cancer. 13(10). 797–805. 58 indexed citations

Wimberger, Pauline, Rainer Kimmig, Felix Hilpert, et al.. (2003). 38 Influence of amifostine on neuroprotection in 1st-line treatment of advanced ovarian cancer with carboplatin/taxane-based chemotherapy - a double-blind, placebo-controlled, randomized phase II-study from the AGO Ovarian Cancer Study Group. European Journal of Cancer Supplements. 1(5). S15–S16. 2 indexed citations

Lengyel, Ernst, Barbara Schmalfeldt, K Späthe, et al.. (2001). Expression of Latent Matrix Metalloproteinase 9 (MMP-9) Predicts Survival in Advanced Ovarian Cancer. Gynecologic Oncology. 82(2). 291–298. 100 indexed citations

Kuhn, Walther, K Späthe, Barbara Schmalfeldt, et al.. (2001). Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Cancer. 92(10). 2585–2591. 151 indexed citations

Schmalfeldt, Barbara, Dieter Prechtel, K Späthe, et al.. (2001). Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.. PubMed. 7(8). 2396–404. 300 indexed citations

Kühn, W., Barbara Schmalfeldt, Ute Reuning, et al.. (1999). Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc. British Journal of Cancer. 79(11-12). 1746–1751. 110 indexed citations

Kühn, W., G. Florack, J. D. Roder, et al.. (1998). The influence of upper abdominal surgery on perioperative morbidity and mortality in patients with advanced ovarian cancer FIGO III and FIGO IV. International Journal of Gynecological Cancer. 8(1). 56–63. 45 indexed citations

Kühn, W., Barbara Schmalfeldt, L. Pache, et al.. (1998). Disease-adapted relapse therapy for ovarian cancer: results of a prospective study.. PubMed. 13(1). 57–63. 20 indexed citations

Kühn, W., Barbara Schmalfeldt, L. Pache, et al.. (1998). Disease-adapted relapse therapy for ovarian cancer: results of a prospective study.. International Journal of Oncology. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact